{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT01297400",
            "orgStudyIdInfo": {
                "id": "MW-III-BURN-2-001"
            },
            "organization": {
                "fullName": "Skingenix, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns",
            "officialTitle": "Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns",
            "therapeuticArea": [
                "Other"
            ],
            "study": "phase-pilot-study-of-the-safety-and-efficacy-of-topical-mw-iii-in-thermal-burns"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-03-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-22",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-22",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2011-02-14",
            "studyFirstSubmitQcDate": "2011-02-15",
            "studyFirstPostDateStruct": {
                "date": "2011-02-16",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-02-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Skingenix, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To compare MW-III to Silvadene\u00ae Cream 1% (Silver Sulfadiazine) with respect to \"time to healing\" (\u226595% re-epithelialization) of a partial thickness target thermal burn.",
            "detailedDescription": "This phase 2 pilot study will assess the safety and efficacy of topical MW-III on thermal burns."
        },
        "conditionsModule": {
            "conditions": [
                "Burns"
            ],
            "keywords": [
                "Burns, Partial Thickness Burns"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Investigational Drug, MW-III",
                    "type": "EXPERIMENTAL",
                    "description": "Investigational Drug, MW-III",
                    "interventionNames": [
                        "Drug: Investigational Drug, MW-III"
                    ]
                },
                {
                    "label": "Standard of care",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Silvadene\u00ae Cream 1% \\[Silver Sulfadiazine\\]",
                    "interventionNames": [
                        "Drug: Silvadene\u00ae Cream 1% [Silver Sulfadiazine]"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Investigational Drug, MW-III",
                    "description": "Topical application, twice a day",
                    "armGroupLabels": [
                        "Investigational Drug, MW-III"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Silvadene\u00ae Cream 1% [Silver Sulfadiazine]",
                    "description": "Topical application, twice a day",
                    "armGroupLabels": [
                        "Standard of care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Time to healing (\u226595% re-epithelialization) of the partial thickness target burn.",
                    "description": "Time to healing (\u226595% re-epithelialization) of the partial thickness target burn.",
                    "timeFrame": "28 days Treatment Period"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Proportion of subjects with partial thickness burns that are healed at each scheduled study assessment.",
                    "description": "Proportion of subjects with partial thickness burns that are healed at each scheduled study assessment.",
                    "timeFrame": "28 days Treatment Period"
                },
                {
                    "measure": "Proportion of subjects with partial thickness burns determined by PI to require skin grafting of burn wound by Day 28.",
                    "description": "Proportion of subjects with partial thickness burns determined by PI to require skin grafting of burn wound by Day 28.",
                    "timeFrame": "28 days Treatment Period"
                },
                {
                    "measure": "Scar scores (POSAS) of the partial thickness target burn and all other partial thickness burns at Day 28.",
                    "description": "Scar scores (POSAS) of the partial thickness target burn and all other partial thickness burns at Day 28.",
                    "timeFrame": "28 days Treatment Period"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Adults, 18 years of age or older on the day of signing the informed consent.\n2. Thermal Burns not exceeding a total body surface area (TBSA) OF 25%, with at least one partial thickness burn of 0.5% TBSA or greater. If full thickness burn(s) are present at screening, the total full thickness burn area shall not exceed 10% TBSA. Note: TBSA excludes areas of superficial (first degree) burns.\n3. Able and willing to give informed consent and comply with study procedures.\n\nExclusion Criteria:\n\n1. Any burn that at screening is:\n\n   1. infected.\n   2. circumferential or deemed, in the judgment of the investigator, at high risk for developing compartment syndrome.\n   3. partial thickness that is likely, in the judgment of the Investigator, to require grafting within 72 hours, or other non-protocol intervention.\n2. Severe inhalation injury or other significant non-burn trauma.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Vicki Christodoulou, MS, JD",
                    "role": "CONTACT",
                    "phone": "909-587-1650",
                    "phoneExt": "1682",
                    "email": "vickic@skingenixusa.com"
                },
                {
                    "name": "Eric Wang, MD",
                    "role": "CONTACT",
                    "phone": "909-587-1650",
                    "phoneExt": "1678",
                    "email": "ericw@skingenixusa.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kevin Foster",
                    "affiliation": "Valleywise Health Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Valleywise Health Medical Center",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85008",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "University of CA Davis Medical Center",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "MedStar Washington Hospital Center",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "Joseph M. Still Burn Center, Doctor's Hospital",
                    "status": "RECRUITING",
                    "city": "Augusta",
                    "state": "Georgia",
                    "zip": "30909",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.47097,
                        "lon": -81.97484
                    }
                },
                {
                    "facility": "University Medical Center New Orleans",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70112",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002056",
                    "term": "Burns"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5326",
                    "name": "Burns",
                    "asFound": "Burn",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013411",
                    "term": "Sulfadiazine"
                },
                {
                    "id": "D000012837",
                    "term": "Silver Sulfadiazine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000000981",
                    "term": "Antiprotozoal Agents"
                },
                {
                    "id": "D000000977",
                    "term": "Antiparasitic Agents"
                },
                {
                    "id": "D000003049",
                    "term": "Coccidiostats"
                },
                {
                    "id": "D000000891",
                    "term": "Anti-Infective Agents, Local"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16197",
                    "name": "Sulfadiazine",
                    "asFound": "Every 2 hours",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15642",
                    "name": "Silver Sulfadiazine",
                    "asFound": "CNS Tumors",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4298",
                    "name": "Antiprotozoal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4294",
                    "name": "Antiparasitic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4215",
                    "name": "Anti-Infective Agents, Local",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}